Skip to main content
TipRanks
Go Ultimate75% OFF

Steven Krill Insider Profile

4 Followers

Steven Krill, EVP & Chief Scientific Officer at Eagle Pharmaceuticals, holds 3.00K shares in Eagle Pharmaceuticals (Ticker: EGRX).

Steven Krill's Trading History

EGRX
Eagle Pharmaceuticals
Jan 09, 2018EVP & Chief Scientific OfficerUninformative Buy―$2.70K
EGRX
Insider Shares: 3.00K (0.02%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 09, 2018Uninformative Buy$0.003,000$0.00―
Mar 24, 2017Informative Sell$1.15M14,125$81.06+34.60%
Mar 24, 2017Uninformative Buy$137.32K14,125$9.72―
Jan 04, 2017Informative Sell$3.86M50,505$76.39+31.00%
Jan 04, 2017Uninformative Buy$1.20M50,505$23.83―

You May Also Like

Steven Krill insider profile FAQ

What is the percentage of profitable transactions made by Steven Krill?
The percentage of profitable transactions made by Steven Krill is 100%.
What is the average return per transaction made by Steven Krill?
The average return per transaction made by Steven Krill is 31.20%.
What stocks does Steven Krill hold?
Steven Krill holds: EGRX stocks.
What was Steven Krill's most profitable transaction?
Steven Krill’s most profitable transaction was an Informative Sell of EGRX stock on June 18, 2015. The return on the trade was 46.30%.
What is Steven Krill's role in Eagle Pharmaceuticals?
Steven Krill's role in Eagle Pharmaceuticals is EVP & Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.